A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer

Name: A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
License: Public Domain

Salma Sabbour

ClinicalTrials.gov · Datasets · License: Public Domain

lung cancer, sclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 474765
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.